Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microbial epoxide hydrolases for preparative biotransformations.

A Steinreiber1, K Faber

  • 1Department of Chemistry, Organic and Bio-organic Chemistry, University of Graz, Heinrichstrasse 28, A-8010 Graz, Austria.

Current Opinion in Biotechnology
|February 19, 2002
PubMed
Summary

Microbial epoxide hydrolases offer efficient asymmetric hydrolysis of epoxides. These biocatalysts enable enantioconvergent synthesis of single diol enantiomers from racemic mixtures, a valuable process in chemical synthesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of the first wave of COVID-19 on Poison Control Centre activities in 21 European countries: an EAPCCT initiative.

Clinical toxicology (Philadelphia, Pa.)·2022
Same author

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS.

Journal of pharmaceutical and biomedical analysis·2016
Same author

A supported liquid extraction-LC-MS/MS method for determination of GDC-0980 (Apitolisib), a dual small-molecule inhibitor of class 1A phosphoinositide 3-kinase and mammalian target of rapamycin, in human plasma.

Journal of pharmaceutical and biomedical analysis·2014
Same author

Haemodialysis in Taxus baccata poisoning: a case report.

QJM : monthly journal of the Association of Physicians·2011
Same author

Tuberculosis in Denmark during the occupation.

Ugeskrift for laeger·2010

Area of Science:

  • Biocatalysis and Enzyme Engineering
  • Organic Chemistry
  • Microbial Biotechnology

Background:

  • Microbial epoxide hydrolases are effective biocatalysts for epoxide transformations.
  • Asymmetric hydrolysis of epoxides is crucial for producing enantiomerically pure compounds.
  • Enantioconvergent processes offer advantages over kinetic resolution for diol synthesis.

Purpose of the Study:

  • To review the capabilities of microbial epoxide hydrolases in asymmetric epoxide hydrolysis.
  • To highlight the potential of enantioconvergent hydrolysis for synthesizing single diol enantiomers.
  • To discuss the substrate selectivity patterns of microbial epoxide hydrolases.

Main Methods:

  • Literature review of microbial epoxide hydrolase applications.

Related Experiment Videos

  • Analysis of substrate structure-selectivity relationships.
  • Comparison of kinetic resolution and enantioconvergent hydrolysis strategies.

    • Main Results:

    • Microbial epoxide hydrolases efficiently perform asymmetric hydrolysis of epoxides.
    • Enantioconvergent hydrolysis yields a single diol enantiomer from racemic epoxides.
    • Established structure-selectivity patterns exist for microbial epoxide hydrolases across various substrates.

    Conclusions:

    • Microbial epoxide hydrolases are versatile tools for preparative asymmetric epoxide hydrolysis.
    • Enantioconvergent processes using these enzymes are highly attractive for synthesizing enantiopure diols.
    • Understanding enzyme selectivity enables tailored biocatalytic routes for diverse epoxide substrates.